← Leaderboards
Joo H Hwang
University Of Washington
$6,295,837
Attributed
$6,295,837
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.3M · FY2006–25$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,658,049 · 6
By mechanism
P01$6,524,908 · 2
R01$4,295,524 · 1
K08$627,885 · 1
R03$155,788 · 1
F32$53,944 · 1
Top collaborators
- Hanlee Ji3 shared
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorUltrasonographyTranslatingPhysiologic PulsePharmaceutical PreparationsIn VivoMalignant NeoplasmsTissuesFocused Ultrasound TherapyMechanicsAnimal ModelGastrointestinalCancer EtiologyResearch PersonnelImageUnited StatesClinical TrialsAnimalsDiagnosisTransducersHemorrhageAcousticsAreaResponse
Grant awards (22)
Precision Interception of Gastric Cancer Precursors Through Molecular and Cellular Risk Stratification$1,843,942
P01 · FY2025 · CA
Project 3: Molecular Risk Stratification of Gastric Precancerous Lesions$415,370
P01 · FY2025 · CA · contact PI
Precision Interception of Gastric Cancer Precursors Through Molecular and Cellular Risk Stratification$1,715,269
P01 · FY2024 · CA
Project 3: Molecular Risk Stratification of Gastric Precancerous Lesions$357,876
P01 · FY2024 · CA · contact PI
Precision Interception of Gastric Cancer Precursors Through Molecular and Cellular Risk Stratification$1,803,001
P01 · FY2023 · CA
Project 3: Molecular Risk Stratification of Gastric Precancerous Lesions$389,450
P01 · FY2023 · CA · contact PI
Ultrasound-enhanced drug penetration for treatment of pancreatic cancer$543,588
R01 · FY2021 · CA · contact PI
Ultrasound-enhanced drug penetration for treatment of pancreatic cancer$591,023
R01 · FY2020 · CA · contact PI
Ultrasound-enhanced drug penetration for treatment of pancreatic cancer$505,134
R01 · FY2019 · CA · contact PI
Ultrasound-enhanced drug penetration for treatment of pancreatic cancer$506,176
R01 · FY2018 · CA · contact PI
Ultrasound-enhanced drug penetration for treatment of pancreatic cancer$498,703
R01 · FY2017 · CA · contact PI
Ultrasound enhanced penetration for treatment of pancreatic cancer$509,766
R01 · FY2013 · CA · contact PI
Ultrasound enhanced penetration for treatment of pancreatic cancer$526,861
R01 · FY2012 · CA · contact PI
Ultrasound enhanced penetration for treatment of pancreatic cancer$614,273
R01 · FY2011 · CA · contact PI
Ultrasound induced vessel thrombosis for treatment of Gastric varices$125,577
K08 · FY2010 · DK · contact PI
High intensity focused ultrasound enhanced drug delivery for local therapy of hep$77,573
R03 · FY2010 · DK · contact PI
Ultrasound induced vessel thrombosis for treatment of Gastric varices$125,577
K08 · FY2009 · DK · contact PI
High intensity focused ultrasound enhanced drug delivery for local therapy of hep$78,215
R03 · FY2009 · DK · contact PI
Ultrasound induced vessel thrombosis for treatment of Gastric varices$125,577
K08 · FY2008 · DK · contact PI
Ultrasound induced vessel thrombosis for treatment of Gastric varices$125,577
K08 · FY2007 · DK · contact PI
US induced vessel thrombosis for treatment of GI varices$125,577
K08 · FY2006 · DK · contact PI
High Intensity Ultrasound in Gastroenterology$53,944
F32 · FY2003 · DK